Călin D. Popa

4.4k total citations · 2 hit papers
59 papers, 3.3k citations indexed

About

Călin D. Popa is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Călin D. Popa has authored 59 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Rheumatology, 15 papers in Immunology and 8 papers in Oncology. Recurrent topics in Călin D. Popa's work include Rheumatoid Arthritis Research and Therapies (27 papers), Systemic Lupus Erythematosus Research (20 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Călin D. Popa is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (27 papers), Systemic Lupus Erythematosus Research (20 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Călin D. Popa collaborates with scholars based in Netherlands, United States and Italy. Călin D. Popa's co-authors include Mihai G. Netea, Piet L. C. M. van Riel, J.W.M. van der Meer, Anton F. H. Stalenhoef, Jaap Fransen, Elke Arts, Leo A. B. Joosten, Alfons A den Broeder, Timothy R. D. J. Radstake and Wim B. van den Berg and has published in prestigious journals such as Cell, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Călin D. Popa

52 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

2007 601 citations Călin D. Popa, Mihai G. Netea et al. Journal of Lipid Research profile →
Metabolic Induction of Trained Immunity through the Mevalonate Pathway

2018 529 citations Siroon Bekkering, Rob J.W. Arts et al. Cell profile →

Peers

Countries citing papers authored by Călin D. Popa

Since Specialization

Citations

This map shows the geographic impact of Călin D. Popa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Călin D. Popa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Călin D. Popa more than expected).

Fields of papers citing papers by Călin D. Popa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Călin D. Popa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Călin D. Popa. The network helps show where Călin D. Popa may publish in the future.

Co-authorship network of co-authors of Călin D. Popa

This figure shows the co-authorship network connecting the top 25 collaborators of Călin D. Popa. A scholar is included among the top collaborators of Călin D. Popa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Călin D. Popa. Călin D. Popa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study 2025 ·European Journal of Preventive Cardiology ·(unknown), (unknown), Isla S. Mackenzie, (unknown), Marcel Flendrie, Călin D. Popa, (unknown), Dina Vojinović, Leo A. B. Joosten, Bas Schouwenberg, Martijn Gerritsen, Alfons A den Broeder, Noortje van Herwaarden	0
2	Diagnostic validation of novel Borrelia antigens discovered by whole-proteome microarray: Advancing early detection and test of cure for Lyme disease 2025 ·Cell Reports Medicine ·(unknown), (unknown), (unknown), Arlo Randall, (unknown), Andy Teng, Jozelyn Pablo, (unknown), (unknown), (unknown), Călin D. Popa, Cees C. van den Wijngaard, Bart Jan Kullberg, Leo A. B. Joosten, (unknown), Joseph J. Campo, X Liang, Joppe W. Hovius	0
3	Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements 2023 ·Annals of Internal Medicine ·(unknown), Aernoud T.L. Fiolet, Arend Mosterd, Jan G.P. Tijssen, Bart J. F. van den Bemt, Astrid Schut, John W. Eikelboom, Peter L. Thompson, C.H.M. van den Ende, Stefan M. Nidorf, Călin D. Popa, Jan H. Cornel	19
4	Clinical Images: Cholesterol crystals bursitis 2023 ·ACR Open Rheumatology ·Călin D. Popa, (unknown)	0
5	Day-to-day fluctuations of fatigue severity in individuals with knee osteoarthritis: an ecological momentary assessment approach 2023 ·Rheumatology Advances in Practice ·(unknown), C.H.M. van den Ende, (unknown), E. Mahler, Călin D. Popa, Johanna E Vriezekolk	1
6	Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial 2021 ·RMD Open ·Laurette van Boheemen, Samina A. Turk, Marian H. van Beers-Tas, Wouter H Bos, (unknown), E. N. Griep, Mirian Starmans‐Kool, Călin D. Popa, (unknown), Maarten Boers, Michael T. Nurmohamed, Dirkjan van Schaardenburg	41
7	Publisher Correction: Cardiovascular effects of approved drugs for rheumatoid arthritis 2021 ·Nature Reviews Rheumatology ·Fabiola Atzeni, Javier Rodríguez‐Carrio, Călin D. Popa, Michael T. Nurmohamed, Gabriella Szűcs, Zoltán Szekanecz	3
8	An add-on training program involving breathing exercises, cold exposure, and meditation attenuates inflammation and disease activity in axial spondyloarthritis – A proof of concept trial 2019 ·PLoS ONE ·Geert A. Buijze, (unknown), Matthijs Kox, Marleen G. van de Sande, Dirkjan van Schaardenburg, Richard M. van Vugt, Călin D. Popa, Peter Pickkers, Dominique Baeten	25
9	Metabolic Induction of Trained Immunity through the Mevalonate Pathway breakdown → 2018 ·Cell ·Siroon Bekkering, Rob J.W. Arts, Boris Novakovic, Ioannis Kourtzelis, Charlotte D.C.C. van der Heijden, Yang Li, Călin D. Popa, Rob ter Horst, Julia van Tuijl, Romana T. Netea‐Maier, Frank L. van de Veerdonk, Triantafyllos Chavakis, Leo A. B. Joosten, J.W.M. van der Meer, Henk G. Stunnenberg, Niels P. Riksen, Mihai G. Netea	529
10	Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study 2017 ·Annals of the Rheumatic Diseases ·Elke Arts, Jaap Fransen, Alfons A den Broeder, Piet L. C. M. van Riel, Călin D. Popa	76
11	The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients 2014 ·Annals of the Rheumatic Diseases ·Elke Arts, Jaap Fransen, Alfons A den Broeder, Călin D. Popa, Piet L. C. M. van Riel	114
12	High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study 2012 ·Arthritis Research & Therapy ·Elke Arts, Jaap Fransen, Heidi Lemmers, Anton F. H. Stalenhoef, Leo A. B. Joosten, Piet L. C. M. van Riel, Călin D. Popa	29
13	Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis 2010 ·Annals of the Rheumatic Diseases ·(unknown), Călin D. Popa, Richard Huijbens, Madelon C Vonk, Michael York, Robert W. Simms, Roger Hesselstrand, Dirk M. Wuttge, Robert Lafyatis, Timothy R. D. J. Radstake	52
14	Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents 2009 ·European Cytokine Network ·Călin D. Popa, Pilar Barrera, Leo A. B. Joosten, Piet L. C. M. van Riel, Bart Jan Kullberg, J.W.M. van der Meer, Mihai G. Netea	17
15	TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop 2009 ·The Journal of Immunology ·Mark H. Wenink, Kim C. M. Santegoets, (unknown), Lenny van Bon, Shahla Abdollahi‐Roodsaz, Călin D. Popa, Richard Huijbens, (unknown), Erik Lubberts, Piet L. C. M. van Riel, Wim B. van den Berg, Timothy R. D. J. Radstake	52
16	Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients 2008 ·Annals of the Rheumatic Diseases ·Călin D. Popa, Lambertus J.H. van Tits, Pilar Barrera, Heidi Lemmers, F.H.J. van den Hoogen, Piet L. C. M. van Riel, Timothy R. D. J. Radstake, Mihai G. Netea, Manon van Roest, Anton F. H. Stalenhoef	99
17	Circulating CXCL16 is not related to circulating oxLDL in patients with rheumatoid arthritis 2007 ·Biochemical and Biophysical Research Communications ·Antoine W.T. van Lieshout, Călin D. Popa, Friederike Meyer‐Wentrup, Heidi Lemmers, Anton F. H. Stalenhoef, Gosse J. Adema, Piet L. C. M. van Riel, Lambertus J. van Tits, Timothy R. D. J. Radstake	11
18	The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk breakdown → 2007 ·Journal of Lipid Research ·Călin D. Popa, Mihai G. Netea, Piet L. C. M. van Riel, J.W.M. van der Meer, Anton F. H. Stalenhoef	601
19	Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy 2005 ·Cytokine ·Călin D. Popa, Mihai G. Netea, Pilar Barrera, Timothy Radstake, Piet L. van Riel, Bart Jan Kullberg, J.W.M. van der Meer	20
20	Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis 2005 ·Annals of the Rheumatic Diseases ·Călin D. Popa, (unknown), (unknown), (unknown), (unknown), (unknown)	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact